The Waqf Amendment Bill has turned out to be a litmus test for BJP-led National Democratic Alliance (NDA) as it has to prove the majority in the Lok Sabha. The government is already facing strong ...
Received positive feedback on New Drug Application submission via the 505(b)(2) pathway-Company leveraging existing human pharmacokinetic data ...
The money employers have to pay employees for legal advice on settlement agreements is not enough to deal with the NDAs they ...
A Labour former minister has called for an end to the “two-tier system of protection”, as she pressed the Government to ...
The Lok Sabha took up the contentious Waqf (Amendment) Bill for discussion and passage today. NDA backed parties including ...
Announced the acceptance of the New Drug Application (NDA) by the U.S. Food and Drug Administration (FDA) for OLC for the treatment of hyperphosphatemia in patients with CKD on dialysis. The FDA set a ...
Bill, 2024, proposes key changes to waqf property management, sparking protests from Muslim organisations and opposition ...
Explore Q1 2025's biotech stock moves, from CervoMed's 300% surge to Septerna's struggles. Click for my review of the quarter ...
Olverembatinib (HQP1351), a novel, next-generation TKI and the first third-generation BCR-ABL1 TKI, has been approved in ...
Falls Supervisors approve relocation of bus charter and tour company to Falls, data centers at Keystone Trade Center, and ...
Discover why Immutep's Eftilagimod Alpha shows promise in NSCLC and HNSCC trials, but cautious investment is advised. Explore more details here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback